The China Securities Regulatory Commission has informally advised humanoid robotics firms to delay IPOs until they demonstrate stable revenue and clear paths to profitability. At least six companies have halted their listing plans, while private valuations for some firms have dropped by 30–50%.
The regulatory shift follows the volatile debut of Unitree Robotics on the Shanghai STAR Market on August 19. The company raised ¥6.1 billion at a valuation of nearly $9 billion. Its stock surged by 460% during one session, pushing market capitalization to ¥445 billion, with a price-to-earnings ratio exceeding 1300.
Following the peak, Unitree shares fell by approximately 55% by late August. Scrutiny intensified after reports revealed that only 9% of the company's revenue came from industrial sales, while 73.6% originated from educational and research clients. Industry experts suggest that some sector revenue relies on non-sustainable schemes.
Despite these hurdles, the Chinese robotics sector remains active, accounting for over 90% of global humanoid robot shipments in the first half of 2026. Recent funding includes $200 million raised by LimX Robotics in July and over $900 million secured by XPeng’s robotics division in August.
